表紙
市場調查報告書
商品編碼
1067985

避孕器的全球市場:產業分析,規模,佔有率,成長,趨勢,預測(2021∼2028年)

Contraceptives Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

出版日期: | 出版商: Transparency Market Research | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球避孕器市場相關調查分析,提供市場概要,產品·流通管道·各地區市場分析,競爭情形相關資訊。

目錄

第1章 序文

第2章 假設與調查手法

第3章 摘要整理:全球避孕器市場

第4章 市場概要

  • 簡介
  • 概要
  • 主要的市場指標
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 全球避孕器市場分析與預測(2017∼2028年)
    • 市場收益預測(100萬美元)
  • 全球避孕器市場-全球供需方案
  • 波特的五力分析
  • 價值鏈分析
  • 市場預測

第5章 全球避孕器市場分析與預測:各產品

  • 簡介和定義
  • 主要調查結果/開發
  • 主要趨勢
  • 市場金額預測:各產品(2017∼2028年)
    • 避孕藥
    • 避孕器具
  • 市場魅力分析:各產品

第6章 全球避孕器市場分析與預測:各流通管道

  • 簡介和定義
  • 主要調查結果/開發
  • 主要趨勢
  • 市場金額預測(2017∼2028年):各流通管道
    • 醫院藥局
    • 獨立的藥局
    • 線上平台
    • 診所
    • 其他
  • 市場魅力分析:各流通管道

第7章 全球避孕器市場分析與預測:各地區

  • 主要調查結果
  • 政策法規
  • 市場金額預測:各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲
  • 市場魅力分析:各國各地區

第8章 北美的避孕器市場分析與預測

  • 簡介
    • 主要調查結果
    • 政策法規
    • 主要趨勢
  • 市場金額預測:各產品(2017∼2028年)
    • 避孕藥
    • 避孕器具
  • 市場金額預測:各流通管道(2017∼2028年)
    • 醫院藥局
    • 獨立的藥局
    • 線上平台
    • 診所
    • 其他
  • 市場金額預測:各國(2017∼2028年)
    • 美國
    • 加拿大
  • 市場魅力分析
    • 各產品
    • 各流通管道
    • 各國

第9章 歐洲的避孕器市場分析與預測

第10章 亞太地區的避孕器市場分析與預測

第11章 南美的避孕器市場分析與預測

第12章 中東及非洲的避孕器市場分析與預測

第13章 競爭情形

  • 市場企業-競爭矩陣(企業的階層與各規模)
  • 市場佔有率分析:各企業(2020年)
  • 企業簡介
    • Merck & Co., Inc.
    • Cipla, Inc.
    • Allergan plc
    • Bayer AG
    • HLL Lifecare Limited
    • Mankind Pharma
    • Pfizer, Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Mithra Pharmaceuticals
    • Janssen Pharmaceutical Company
    • Reckitt Benckiser Group plc
目錄
Product Code: TMRGL344

Scope of the Report

TMR's report on the global contraceptives market studies past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global contraceptives market for the period 2017-2028, considering 2018 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global contraceptives market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global contraceptives market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global contraceptives market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global contraceptives market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global contraceptives market.

The report delves into the competition landscape of the global contraceptives market. Key players operating in the global contraceptives market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global contraceptives market that have been profiled in this report.

Key Questions Answered:

  • What is the scope of growth of product companies in the global contraceptives market?
  • What will be the Y-o-Y growth of the global contraceptives market between 2017 and 2028?
  • What is the influence of changing trends in technologies on the global contraceptives market?
  • Will North America to be the most profitable market for contraceptives devices providers?
  • Which factors are anticipated to hamper the growth of the global contraceptives market during the forecast period?
  • Which are the leading companies in the global contraceptives market?

Research Methodology

A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global contraceptives market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global contraceptives market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR's study on the contraceptives market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the contraceptives market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global contraceptives market with accuracy. The study also uses the top-down approach to assess the revenue for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR's estimates on future prospects of the global contraceptives market more reliably and accurately.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Contraceptives Market

4. Market Overview

  • 4.1. Introduction
  • 4.2. Overview
  • 4.3. Key Market Indicators
  • 4.4. Market Dynamics
    • 4.4.1. Drivers
    • 4.4.2. Restraints
    • 4.4.3. Opportunity
  • 4.5. Global Contraceptives Market Analysis and Forecast, 2017-2028
    • 4.5.1. Market Revenue Projections (US$ Mn)
  • 4.6. Global Contraceptives Market - Global Supply Demand Scenario
  • 4.7. Porter's Five Force Analysis
  • 4.8. Value Chain Analysis
  • 4.9. Market Outlook

5. Global Contraceptives Market Analysis and Forecast, By Product

  • 5.1. Introduction & Definition
  • 5.2. Key Findings / Developments
  • 5.3. Key Trends
  • 5.4. Market Value Forecast, by Product, 2017-2028
    • 5.4.1. Contraceptives Drugs
      • 5.4.1.1. Oral Contraceptives
        • 5.4.1.1.1. Combined Contraceptives
        • 5.4.1.1.2. Mini-pills
      • 5.4.1.2. Contraceptive Injectable
      • 5.4.1.3. Topical Contraceptive Patch
    • 5.4.2. Contraceptive Devices
      • 5.4.2.1. Male Contraceptive Devices
      • 5.4.2.2. Female Contraceptive Devices
        • 5.4.2.2.1. Female Condoms
        • 5.4.2.2.2. Contraceptive Diaphragms
        • 5.4.2.2.3. Contraceptive Sponges
        • 5.4.2.2.4. Contraceptive Vaginal Rings
        • 5.4.2.2.5. Intrauterine Devices
        • 5.4.2.2.6. Sub-dermal Contraceptives Implants
        • 5.4.2.2.7. Non-Surgical Permanent Contraception Devices
  • 5.5. Market Attractiveness Analysis, By Product

6. Global Contraceptives Market Analysis and Forecast, By Distribution Channel

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Key Trends
  • 6.4. Market Value Forecast, by Distribution Channel, 2017-2028
    • 6.4.1. Hospital Pharmacy
      • 6.4.1.1. Public
      • 6.4.1.2. Private
    • 6.4.2. Independent Pharmacy
    • 6.4.3. Online Platform
    • 6.4.4. Clinics
    • 6.4.5. Others
  • 6.5. Market Attractiveness Analysis, By Distribution Channel

7. Global Contraceptives Market Analysis and Forecast, By Region

  • 7.1. Key Findings
  • 7.2. Policies and Regulations
  • 7.3. Market Value Forecast, by Region
    • 7.3.1. North America
    • 7.3.2. Europe
    • 7.3.3. Asia Pacific
    • 7.3.4. Latin America
    • 7.3.5. Middle East and Africa
  • 7.4. Market Attractiveness Analysis, By Country/Region

8. North America Contraceptives Market Analysis and Forecast

  • 8.1. Introduction
    • 8.1.1. Key Findings
    • 8.1.2. Policies and Regulations
    • 8.1.3. Key Trends
  • 8.2. Market Value Forecast, by Product, 2017-2028
    • 8.2.1. Contraceptive Drugs
      • 8.2.1.1. Oral Contraceptives
        • 8.2.1.1.1. Combined Contraceptives
        • 8.2.1.1.2. Mini-pills
      • 8.2.1.2. Contraceptive Injectable
      • 8.2.1.3. Topical Contraceptive Patch
    • 8.2.2. Contraceptive Devices
      • 8.2.2.1. Male Contraceptive Devices
      • 8.2.2.2. Female Contraceptive Devices
        • 8.2.2.2.1. Female Condoms
        • 8.2.2.2.2. Contraceptive Diaphragms
        • 8.2.2.2.3. Contraceptive Sponges
        • 8.2.2.2.4. Contraceptive Vaginal Rings
        • 8.2.2.2.5. Intrauterine Devices
        • 8.2.2.2.6. Sub-dermal Contraceptives Implants
        • 8.2.2.2.7. Non-Surgical Permanent Contraception Devices
  • 8.3. Market Value Forecast, by Distribution Channel, 2017-2028
    • 8.3.1. Hospital Pharmacy
      • 8.3.1.1. Public
      • 8.3.1.2. Private
    • 8.3.2. Independent Pharmacy
    • 8.3.3. Online Platform
    • 8.3.4. Clinics
    • 8.3.5. Others
  • 8.4. Market Value Forecast, by Country, 2017-2028
    • 8.4.1. U.S.
    • 8.4.2. Canada
  • 8.5. Market Attractiveness Analysis
    • 8.5.1. By Product
    • 8.5.2. By Distribution Channel
    • 8.5.3. By Country

9. Europe Contraceptives Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
    • 9.1.2. Policies and Regulations
    • 9.1.3. Key Trends
  • 9.2. Market Value Forecast, by Product, 2017-2028
    • 9.2.1. Contraceptive Drugs
      • 9.2.1.1. Oral Contraceptives
        • 9.2.1.1.1. Combined Contraceptives
        • 9.2.1.1.2. Mini-pills
      • 9.2.1.2. Contraceptive Injectable
      • 9.2.1.3. Topical Contraceptive Patch
    • 9.2.2. Contraceptive Devices
      • 9.2.2.1. Male Contraceptive Devices
      • 9.2.2.2. Female Contraceptive Devices
        • 9.2.2.2.1. Female Condoms
        • 9.2.2.2.2. Contraceptive Diaphragms
        • 9.2.2.2.3. Contraceptive Sponges
        • 9.2.2.2.4. Contraceptive Vaginal Rings
        • 9.2.2.2.5. Intrauterine Devices
        • 9.2.2.2.6. Sub-dermal Contraceptives Implants
        • 9.2.2.2.7. Non-Surgical Permanent Contraception Devices
  • 9.3. Market Value Forecast, by Distribution Channel, 2017-2028
    • 9.3.1. Hospital Pharmacy
      • 9.3.1.1. Public
      • 9.3.1.2. Private
    • 9.3.2. Independent Pharmacy
    • 9.3.3. Online Platform
    • 9.3.4. Clinics
    • 9.3.5. Others
  • 9.4. Market Value Forecast, by Country/Sub-region, 2017-2028
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. U.K.
    • 9.4.4. Spain
    • 9.4.5. Italy
    • 9.4.6. Russia
    • 9.4.7. Rest of Europe
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Product
    • 9.5.2. By Distribution Channel
    • 9.5.3. By Country/Sub-region

10. Asia Pacific Contraceptives Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
    • 10.1.2. Policies and Regulations
    • 10.1.3. Key Trends
  • 10.2. Market Value Forecast, by Product, 2017-2028
    • 10.2.1. Contraceptive Drugs
      • 10.2.1.1. Oral Contraceptives
        • 10.2.1.1.1. Combined Contraceptives
        • 10.2.1.1.2. Mini-pills
      • 10.2.1.2. Contraceptive Injectable
      • 10.2.1.3. Topical Contraceptive Patch
    • 10.2.2. Contraceptive Devices
      • 10.2.2.1. Male Contraceptive Devices
      • 10.2.2.2. Female Contraceptive Devices
        • 10.2.2.2.1. Female Condoms
        • 10.2.2.2.2. Contraceptive Diaphragms
        • 10.2.2.2.3. Contraceptive Sponges
        • 10.2.2.2.4. Contraceptive Vaginal Rings
        • 10.2.2.2.5. Intrauterine Devices
        • 10.2.2.2.6. Sub-dermal Contraceptives Implants
        • 10.2.2.2.7. Non-Surgical Permanent Contraception Devices
  • 10.3. Market Value Forecast, by Distribution Channel, 2017-2028
    • 10.3.1. Hospital Pharmacy
      • 10.3.1.1. Public
      • 10.3.1.2. Private
    • 10.3.2. Independent Pharmacy
    • 10.3.3. Online Platforms
    • 10.3.4. Clinics
    • 10.3.5. Others
  • 10.4. Market Value Forecast, by Country/Sub-region, 2017-2028
    • 10.4.1. China
    • 10.4.2. Japan
    • 10.4.3. India
    • 10.4.4. Australia & New Zealand
    • 10.4.5. Rest of Asia Pacific
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Product
    • 10.5.2. By Distribution Channel
    • 10.5.3. By Country/Sub-region

11. Latin America Contraceptives Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
    • 11.1.2. Policies and Regulations
    • 11.1.3. Key Trends
  • 11.2. Market Value Forecast, by Product, 2017-2028
    • 11.2.1. Contraceptive Drugs
      • 11.2.1.1. Oral Contraceptives
        • 11.2.1.1.1. Combined Contraceptives
        • 11.2.1.1.2. Mini-pills
      • 11.2.1.2. Contraceptive Injectable
      • 11.2.1.3. Topical Contraceptive Patch
    • 11.2.2. Contraceptive Devices
      • 11.2.2.1. Male Contraceptive Devices
      • 11.2.2.2. Female Contraceptive Devices
        • 11.2.2.2.1. Female Condoms
        • 11.2.2.2.2. Contraceptive Diaphragms
        • 11.2.2.2.3. Contraceptive Sponges
        • 11.2.2.2.4. Contraceptive Vaginal Rings
        • 11.2.2.2.5. Intrauterine Devices
        • 11.2.2.2.6. Sub-dermal Contraceptives Implants
        • 11.2.2.2.7. Non-Surgical Permanent Contraception Devices
  • 11.3. Market Value Forecast, by Distribution Channel, 2017-2028
    • 11.3.1. Hospital Pharmacy
      • 11.3.1.1. Public
      • 11.3.1.2. Private
    • 11.3.2. Independent Pharmacy
    • 11.3.3. Online Platforms
    • 11.3.4. Clinics
    • 11.3.5. Others
  • 11.4. Market Value Forecast, by Country/Sub-region, 2017-2028
    • 11.4.1. Brazil
    • 11.4.2. Mexico
    • 11.4.3. Rest of Latin America
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Product
    • 11.5.2. By Distribution Channel
    • 11.5.3. By Country/Sub-region

12. Middle East and Africa Contraceptives Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
    • 12.1.2. Policies and Regulations
    • 12.1.3. Key Trends
  • 12.2. Market Value Forecast, by Product, 2017-2028
    • 12.2.1. Contraceptive Drugs
      • 12.2.1.1. Oral Contraceptives
        • 12.2.1.1.1. Combined Contraceptives
        • 12.2.1.1.2. Mini-pills
      • 12.2.1.2. Contraceptive Injectable
      • 12.2.1.3. Topical Contraceptive Patch
    • 12.2.2. Contraceptive Devices
      • 12.2.2.1. Male Contraceptive Devices
      • 12.2.2.2. Female Contraceptive Devices
        • 12.2.2.2.1. Female Condoms
        • 12.2.2.2.2. Contraceptive Diaphragms
        • 12.2.2.2.3. Contraceptive Sponges
        • 12.2.2.2.4. Contraceptive Vaginal Rings
        • 12.2.2.2.5. Intrauterine Devices
        • 12.2.2.2.6. Sub-dermal Contraceptives Implants
        • 12.2.2.2.7. Non-Surgical Permanent Contraception Devices
  • 12.3. Market Value Forecast, by End User, 2017-2028
    • 12.3.1. Hospital Pharmacy
      • 12.3.1.1. Public
      • 12.3.1.2. Private
    • 12.3.2. Independent Pharmacy
    • 12.3.3. Online Platform
    • 12.3.4. Clinics
    • 12.3.5. Others
  • 12.4. Market Value Forecast, by Country /Sub-region, 2017-2028
    • 12.4.1. GCC Countries
    • 12.4.2. South Africa
    • 12.4.3. Rest of Middle East and Africa
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Product
    • 12.5.2. By Distribution Channel
    • 12.5.3. By Country/Sub-region

13. Competition Landscape

  • 13.1. Market Player - Competition Matrix (by tier and size of companies)
  • 13.2. Market Share Analysis, by Company, 2020
  • 13.3. Company Profiles
    • 13.3.1. Merck & Co., Inc.
      • 13.3.1.1. Overview
      • 13.3.1.2. Financials
      • 13.3.1.3. Recent Developments
      • 13.3.1.4. Strategy
    • 13.3.2. Cipla, Inc.
      • 13.3.2.1. Overview
      • 13.3.2.2. Financials
      • 13.3.2.3. Recent Developments
      • 13.3.2.4. Strategy
    • 13.3.3. Allergan plc
      • 13.3.3.1. Overview
      • 13.3.3.2. Financials
      • 13.3.3.3. Recent Developments
      • 13.3.3.4. Strategy
    • 13.3.4. Bayer AG
      • 13.3.4.1. Overview
      • 13.3.4.2. Financials
      • 13.3.4.3. Recent Developments
      • 13.3.4.4. Strategy
    • 13.3.5. HLL Lifecare Limited
      • 13.3.5.1. Overview
      • 13.3.5.2. Financials
      • 13.3.5.3. Recent Developments
      • 13.3.5.4. Strategy
    • 13.3.6. Mankind Pharma
      • 13.3.6.1. Overview
      • 13.3.6.2. Financials
      • 13.3.6.3. Recent Developments
      • 13.3.6.4. Strategy
    • 13.3.7. Pfizer, Inc.
      • 13.3.7.1. Overview
      • 13.3.7.2. Financials
      • 13.3.7.3. Recent Developments
      • 13.3.7.4. Strategy
    • 13.3.8. Teva Pharmaceutical Industries Ltd.
      • 13.3.8.1. Overview
      • 13.3.8.2. Financials
      • 13.3.8.3. Recent Developments
      • 13.3.8.4. Strategy
    • 13.3.9. Mithra Pharmaceuticals
      • 13.3.9.1. Overview
      • 13.3.9.2. Financials
      • 13.3.9.3. Recent Developments
      • 13.3.9.4. Strategy
    • 13.3.10. Janssen Pharmaceutical Company
      • 13.3.10.1. Overview
      • 13.3.10.2. Financials
      • 13.3.10.3. Recent Developments
      • 13.3.10.4. Strategy
    • 13.3.11. Reckitt Benckiser Group plc
      • 13.3.11.1. Overview
      • 13.3.11.2. Financials
      • 13.3.11.3. Recent Developments
      • 13.3.11.4. Strategy

List of Tables

  • Table 01: Global Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2017-2028
  • Table 02: Global Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2017-2028
  • Table 03: Global Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2017-2028
  • Table 04: Global Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2017-2028
  • Table 05: Global Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2017-2028
  • Table 06: Global Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2028
  • Table 07: Global Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2017-2028
  • Table 08: Global Contraceptives Market Size (US$ Mn) Forecast, by Region, 2017-2028
  • Table 09: North America Contraceptives Market Size (US$ Mn) Forecast, by Country, 2017-2028
  • Table 10: North America Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2017-2028
  • Table 11: North America Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2017-2028
  • Table 12: North America Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2017-2028
  • Table 13: North America Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2017-2028
  • Table 14: North America Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2017-2028
  • Table 15: North America Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2028
  • Table 16: North America Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2017-2028
  • Table 17: Europe Contraceptives Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2028
  • Table 18: Europe Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2017-2028
  • Table 19: Europe Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2017-2028
  • Table 20: Europe Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2017-2028
  • Table 21: Europe Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2017-2028
  • Table 22: Europe Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2017-2028
  • Table 23: Europe Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2028
  • Table 24: Europe Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2017-2028
  • Table 25: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2028
  • Table 26: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2017-2028
  • Table 27: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2017-2028
  • Table 28: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2017-2028
  • Table 29: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2017-2028
  • Table 30: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2017-2028
  • Table 31: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2028
  • Table 32: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2017-2028
  • Table 33: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2028
  • Table 34: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2017-2028
  • Table 35: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2017-2028
  • Table 36: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2017-2028
  • Table 37: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2017-2028
  • Table 38: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2017-2028
  • Table 39: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2028
  • Table 40: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2017-2028
  • Table 41: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2028
  • Table 42: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2017-2028
  • Table 43: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2017-2028
  • Table 44: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2017-2028
  • Table 45: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2017-2028
  • Table 46: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2017-2028
  • Table 47: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2028
  • Table 48: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2017-2028

List of Figures

  • Figure 01: Global Contraceptives, Market Size (US$ Mn) Forecast, 2017-2028
  • Figure 02: Global Contraceptives Market Value Share, by Product (2020)
  • Figure 03: Global Contraceptives Market Value Share, by Distribution Channel, 2020
  • Figure 04: Global Contraceptives Market Value Share, by Region, 2020
  • Figure 05: Global Contraceptives Market Value Share, by Product Type, 2017 and 2028
  • Figure 06: Global Contraceptives Market Attractiveness Analysis, by Product Type, 2017-2028
  • Figure 07: Global Contraceptives Market Value Share, by Contraceptive Drugs, 2017 and 2028
  • Figure 08: Global Contraceptives Market Attractiveness Analysis, by Contraceptive Drugs, 2017-2028
  • Figure 09: Global Contraceptives Market Value Share, by Oral Contraceptives, 2017 and 2028
  • Figure 10: Global Contraceptives Market Attractiveness Analysis, by Oral Contraceptives, 2017-2028
  • Figure 11: Global Contraceptives Market Value Share, by Contraceptive Devices, 2017 and 2028
  • Figure 12: Global Contraceptives Market Attractiveness Analysis, by Contraceptive Devices, 2017-2028
  • Figure 13: Global Contraceptives Market Value Share, by Female Contraceptive Devices, 2017 and 2028
  • Figure 14: Global Contraceptives Market Attractiveness Analysis, by Female Contraceptive Devices, 2017-2028
  • Figure 15: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Contraceptive Drugs, 2017-2028
  • Figure 16: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Contraceptive Devices, 2017-2028
  • Figure 17: Global Contraceptives Market Value Share, by Distribution Channel, 2017 and 2028
  • Figure 18: Global Contraceptives Market Attractiveness Analysis, by Distribution Channel, 2017-2028
  • Figure 19: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospital Pharmacy, 2017-2028
  • Figure 20: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Independent Pharmacy, 2017-2028
  • Figure 21: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Online Platform, 2017-2028
  • Figure 22: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Clinic, 2017-2028
  • Figure 23: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017-2028
  • Figure 24: Global Contraceptives Market Value Share, by Region, 2017 and 2028
  • Figure 25: Global Contraceptives Market Attractiveness Analysis, by Region, 2017-2028
  • Figure 26: North America Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2028
  • Figure 27: North America Contraceptives Market Attractiveness Analysis, by Country 2017-2028
  • Figure 28: North America Contraceptives Market Value Share, by Country, 2017 and 2028
  • Figure 29: North America Contraceptives Market Value Share, by Product Type, 2017 and 2028
  • Figure 30: North America Contraceptives Market Attractiveness Analysis, by Product Type, 2017-2028
  • Figure 31: North America Contraceptives Market Value Share, by Distribution Channel, 2017 and 2028
  • Figure 32: North America Contraceptives Market Attractiveness Analysis, by Distribution Channel, 2017-2028
  • Figure 33: Europe Contraceptives Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2028
  • Figure 34: Europe Contraceptives Market Attractiveness Analysis, by Country/Sub-region, 2017-2028
  • Figure 35: Europe Contraceptives Market Value Share, by Country/Sub-region, 2017 and 2028
  • Figure 36: Europe Contraceptives Market Value Share, by Product, 2017 and 2028
  • Figure 37: Europe Contraceptives Market Attractiveness Analysis, by Product, 2017-2028
  • Figure 38: Europe Contraceptives Market Value Share, by Distribution Channel, 2017 and 2028
  • Figure 39: Europe Contraceptives Market Attractiveness Analysis, by Distribution Channel, 2017-2028
  • Figure 40: Asia Pacific Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2028
  • Figure 41: Asia Pacific Contraceptives Market Attractiveness Analysis, by Country/Sub-region, 2017-2028
  • Figure 42: Asia Pacific Contraceptives Market Value Share, by Country/Sub-region, 2017 and 2028
  • Figure 43: Asia Pacific Contraceptives Market Value Share, by Product Type, 2017 and 2028
  • Figure 44: Asia Pacific Contraceptives Market Attractiveness Analysis, by Product Type, 2017-2028
  • Figure 45: Asia Pacific Contraceptives Market Value Share, by Distribution Channel, 2017 and 2028
  • Figure 46: Asia Pacific Contraceptives Market Attractiveness Analysis, by Distribution Channel, 2017-2028
  • Figure 47: Latin America Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2028
  • Figure 48: Latin America Contraceptives Market Attractiveness Analysis, by Country/Sub-region, 2017-2028
  • Figure 49: Latin America Contraceptives Market Value Share, by Country/Sub-region, 2017 and 2028
  • Figure 50: Latin America Contraceptives Market Value Share, by Product Type, 2017 and 2028
  • Figure 51: Latin America Contraceptives Market Attractiveness Analysis, by Product Type, 2017-2028
  • Figure 52: Latin America Contraceptives Market Value Share, by Distribution Channel, 2017 and 2028
  • Figure 53: Latin America Contraceptives Market Attractiveness Analysis, by Distribution Channel, 2017-2028
  • Figure 54: Middle East & Africa Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2028
  • Figure 55: Middle East & Africa Contraceptives Market Attractiveness Analysis, by Country/Sub-region, 2017-2028
  • Figure 56: Middle East & Africa Contraceptives Market Value Share, by Country/Sub-region, 2017 and 2028
  • Figure 57: Middle East & Africa Contraceptives Market Value Share, by Product Type, 2017 and 2028
  • Figure 58: Middle East & Africa Contraceptives Market Attractiveness Analysis, by Product Type, 2017-2028
  • Figure 59: Middle East & Africa Contraceptives Market Value Share, by Distribution Channel, 2017 and 2028
  • Figure 60: Middle East & Africa Contraceptives Market Attractiveness Analysis, by Distribution Channel, 2017-2028
  • Figure 61: Global Contraceptives Drugs Market Share, by Company, 2020
  • Figure 62: Global Contraceptives Devices Market Share, by Company, 2020